
June 21, 2022
Phase 3 Study Shows Fezolinetant Reduces Frequency, Severity of Menopausal Hot Flashes
Genevieve Neal-Perry, MD, PhD, Distinguished Professor and Chair of Obstetrics and Gynecology, presented findings of this industry-sponsored study at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta.